Related Experiment Video
Updated: May 28, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?
Michael Kaplan1, Ruben Bromiker, Cathy Hammerman
1Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel. kaplan@cc.huji.ac.il
Insights
Bilirubin encephalopathy and kernicterus remain significant threats to newborns, even in developed nations. Continued vigilance and improved management strategies are crucial to minimize this preventable brain damage.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
Background:
- Bilirubin encephalopathy and kernicterus cause permanent brain damage in newborns.
- These conditions persist globally, affecting both developing and developed countries.
- Existing guidelines for jaundice detection and hyperbilirubinemia treatment have not eradicated the problem.
Purpose of the Study:
- To review current aspects of bilirubin encephalopathy and kernicterus.
- To highlight recent severe cases and discuss contributing factors.
- To identify strategies for reducing bilirubin-related harm.
Main Methods:
- Review of recent literature and case reports on severe hyperbilirubinemia and kernicterus.
- Analysis of factors contributing to the persistence of these conditions.
- Synthesis of current knowledge on management and prevention.
Main Results:
- Severe hyperbilirubinemia and kernicterus continue to be reported worldwide.
- Multiple factors contribute to the ongoing incidence of these conditions.
- Effective strategies are needed to further reduce bilirubin-related morbidity and mortality.
Conclusions:
- Bilirubin encephalopathy and kernicterus remain significant clinical challenges.
- A comprehensive approach is necessary to address the multifactorial causes.
- Further efforts are required to minimize and prevent bilirubin-induced neurological damage in neonates.
Abstract:
Despite efforts to eliminate permanent and irreversible brain damage due to bilirubin encephalopathy and kernicterus, these conditions continue to accompany us into the third millennium. This phenomenon occurs not only in developing countries with emerging medical systems, but in Westernized countries as well. Comprehensive guidelines to detect newborns with jaundice and treat those in whom hyperbilirubinemia has already developed have been formulated in several countries, but have not been successful in completely eliminating the problem. In this appraisal of the situation we review selected aspects of bilirubin encephalopathy and/or kernicterus. We highlight recent reports of severe hyperbilirubinemia and kernicterus, discuss some of the factors responsible for the continuing appearance of these conditions, and briefly review what can be done to decrease bilirubin-related morbidity and mortality to the minimum.
Related Concept Videos
Jaundice
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inborn Errors of Metabolism
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

